相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Indoleamine 2,3 dioxygenase in intestinal disease
Matthew A. Ciorba
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy
Monica Cavia-Saiz et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2012)
Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP
Soranobu Ninomiya et al.
ANNALS OF HEMATOLOGY (2011)
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers
R. Mead et al.
BRITISH JOURNAL OF CANCER (2011)
Suppression of T-cell responses by tumor metabolites
Katrin Singer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases
Cheng-Bao Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas
Klaus Laimer et al.
ORAL ONCOLOGY (2011)
The dimensions of the CRC problem
L. V. Karsa et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP
Takeshi Yoshikawa et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Identification of biomarkers for colorectal cancer through proteomics-based approaches
Harold Tjalsma
EXPERT REVIEW OF PROTEOMICS (2010)
Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy
Tomoko Inaba et al.
GYNECOLOGIC ONCOLOGY (2010)
The use of survival analysis for clinical pathways
Seval Kul
INTERNATIONAL JOURNAL OF CARE COORDINATION (2010)
The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
Yan-Fang Gao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein Microarrays
Ingrid Babel et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer
Ann Willman Silk et al.
MOLECULAR IMMUNOLOGY (2009)
Profiling tumor-associated autoantibodies for the detection of colon cancer
Yuliang Ran et al.
CLINICAL CANCER RESEARCH (2008)
Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: Its association with disease progression and survival
Kazuhiko Ino et al.
CLINICAL CANCER RESEARCH (2008)
Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
Ke Pan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Mechanisms of local immunosuppression in cutaneous melanoma
M. E. Polak et al.
BRITISH JOURNAL OF CANCER (2007)
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
Estimating the probability of cancer with several tumor markers in patients with colorectal disease
M Carpelan-Holmstrom et al.
ONCOLOGY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
MJ Duffy et al.
EUROPEAN JOURNAL OF CANCER (2003)
分享论文
